Skip to main content
Search
Search
Advanced Search
Skip main navigation
Free access
Research Article
6 March 2020

Clinical therapeutic efficacy of mesenchymal stem cells derived from adipose or bone marrow for knee osteoarthritis: a meta-analysis of randomized controlled trials

Authors: Xinxin Han, Bo Yang, Fagui Zou, and Jianbo Sun [email protected]Author Info & Affiliations
Volume 9, Number 5
https://doi.org/10.2217/cer-2019-0187
PDFFormats

Abstract

Aim: This meta-analysis, only including randomized controlled trials (RCTs), was conducted to assess separately and compare the therapeutic efficacy of adipose-derived mesenchymal stem cells (ADMSCs) and bone marrow-derived mesenchymal stem cells (BMSCs) for knee osteoarthritis (OA) at the same follow-up time. Methods: Potential relevant researches were identified from PubMed, Web of Science, Embase, Cochrane Library and clinicaltrials.gov. The data, from clinical trials concentrating on knee OA treated with ADMSCs or BMSCs, were extracted and pooled for meta-analysis to compare the clinical outcomes of patients with knee OA in visual analog scale (VAS), Western Ontario McMaster Universities Osteoarthritis Index (WOMAC), Lysholm knee scale (Lysholm) and Tegner activity scale (Tegner). Results: Nine randomized controlled trials including a total of 377 patients met the inclusion criteria. This meta-analysis obtained the following results. First, the improvement of VAS scores was statistically significant after BMSCs treatment at 6-, 12- and 24-month follow-up compared with control groups (p < 0.01). In contrast, the improvement of WOMAC scores was of no statistical significance, but showed a positive trend with the prolongation of the follow-up time (6 months: mean difference [MD] = 6.51; 95% CI: -2.38 to 15.40; p = 0.15; 12 months: MD = -6.81; 95% CI: -13.94 to 0.33; p = 0.06). Lysholm scores presented a similar pattern (12 months: MD = 1.93; 95% CI: -11.52 to 15.38; p = 0.78; 24 months: MD = 8.94; 95% CI: 1.45 to 16.43; p = 0.02). Second, VAS and WOMAC scores of patients after ADMSCs treatment were significantly improved at any follow-up time (p ≤ 0.05). The improvement of Lysholm scores was of no statistical significance compared with control groups, although treatment outcome at 12-month follow-up was better than that at 24-month follow-up, which was debatable because only data of one clinical trial were pooled in the analysis (12 months: MD = 7.50; 95% CI: -1.94 to 16.94; p = 0.12; 24 months: MD = 5.10; 95% CI: -3.02 to 13.22; p = 0.22). Finally, by comparing the statistical results of VAS and WOMAC scores, it could be concluded that the therapeutic effect of ADMSCs on knee OA was more effective than that of BMSCs. Conclusion: This meta-analysis showed that regeneration with BMSCs or ADMSCs had a great application potential in the treatment of patients with knee OA, and ADMSCs tended to be superior to BMSCs according to the limited clinical evidences available.

Formats available

You can view the full content in the following formats:

View PDFView Full Text

References

1.
Castrogiovanni P, Di Rosa M, Ravalli S et al. Moderate physical activity as a prevention method for knee osteoarthritis and the role of synoviocytes as biological key. Int. J. Mol. Sci. 20(3), 511 (2019).
PubMed
Google Scholar
2.
Morille M, Toupet K, Montero-Menei CN, Jorgensen C, Noël D. PLGA-based microcarriers induce mesenchymal stem cell chondrogenesis and stimulate cartilage repair in osteoarthritis. Biomaterials 88, 60–69 (2016).
PubMed
Google Scholar
3.
Pap T, Korb-Pap A. Cartilage damage in osteoarthritis and rheumatoid arthritis – two unequal siblings. Nature Rev. Rheumatol. 11(10), 606–615 (2015).
PubMed
Google Scholar
4.
Hunter DJ, Bierma-Zeinstra S. Osteoarthritis. Lancet 393(10182), 1745–1759 (2019).
PubMed
Google Scholar
5.
Michael JW, Schluter-Brust KU, Eysel P. The epidemiology, etiology, diagnosis, and treatment of osteoarthritis of the knee. Dtsch Arztebl. Int. 107(9), 152–162 (2010).
PubMed
Google Scholar
6.
Neogi T. The epidemiology and impact of pain in osteoarthritis. Osteoarthritis Cartilage 21(9), 1145–1153 (2013).
PubMed
Google Scholar
7.
Pas HI, Winters M, Haisma HJ, Koenis MJ, Tol JL, Moen MH. Stem cell injections in knee osteoarthritis: a systematic review of the literature. Br. J. Sports Med. 51(15), 1125–1133 (2017).
PubMed
Google Scholar
8.
Castorina S, Guglielmino C, Castrogiovanni P et al. Clinical evidence of traditional vs fast track recovery methodologies after total arthroplasty for osteoarthritic knee treatment. A retrospective observational study. Muscles Ligaments Tendons J. 7(3), 504–513 (2017).
PubMed
Google Scholar
9.
Bannuru RR, Osani MC, Vaysbrot EE et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage 27(11), 1578–1589 (2019).
PubMed
Google Scholar
10.
Szychlinska MA, Castrogiovanni P, Trovato FM et al. Physical activity and Mediterranean diet based on olive tree phenolic compounds from two different geographical areas have protective effects on early osteoarthritis, muscle atrophy and hepatic steatosis. Eur. J. Nutr. 58(2), 565–581 (2019).
PubMed
Google Scholar
11.
Szychlinska MA, Imbesi R, Castrogiovanni P et al. Assessment of vitamin D supplementation on articular cartilage morphology in a young healthy sedentary rat model. Nutrients 11(6), 1260 (2019).
PubMed
Google Scholar
12.
Ghouri A, Conaghan PG. Update on novel pharmacological therapies for osteoarthritis. Ther. Adv. Musculoskelet. Dis. 11, (2019).
Crossref
PubMed
Google Scholar
13.
Jevotovsky DS, Alfonso AR, Einhorn TA, Chiu ES. Osteoarthritis and stem cell therapy in humans: a systematic review. Osteoarthritis Cartilage 26(6), 711–729 (2018).
PubMed
Google Scholar
14.
Liddle AD, Judge A, Pandit H, Murray DW. Adverse outcomes after total and unicompartmental knee replacement in 101 330 matched patients: a study of data from the National Joint Registry for England and Wales. Lancet 384(9952), 1437–1445 (2014).
PubMed
Google Scholar
15.
Rongen JJ, Rovers MM, Van Tienen TG, Buma P, Hannink G. Increased risk for knee replacement surgery after arthroscopic surgery for degenerative meniscal tears: a multi-center longitudinal observational study using data from the osteoarthritis initiative. Osteoarthritis Cartilage 25(1), 23–29 (2017).
PubMed
Google Scholar
16.
Wylde V, Hewlett S, Learmonth ID, Dieppe P. Persistent pain after joint replacement: prevalence, sensory qualities, and postoperative determinants. Pain 152(3), 566–572 (2011).
PubMed
Google Scholar
17.
Park YB, Ha CW, Rhim JH, Lee HJ. Stem cell therapy for articular cartilage repair: review of the entity of cell populations used and the result of the clinical application of each entity. Am. J. Sports Med. 46(10), 2540–2552 (2018).
PubMed
Google Scholar
18.
Wang LT, Ting CH, Yen ML et al. Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: review of current clinical trials. J. Biomed. Sci. 23(1), 76 (2016).
PubMed
Google Scholar
19.
Li C, Jin Y, Wei S et al. Hippo signaling controls NLR family pyrin domain containing 3 activation and governs immunoregulation of mesenchymal stem cells in mouse liver injury. Hepatology 70(5), 1714–1731 (2019).
PubMed
Google Scholar
20.
Lin W, Xu L, Zwingenberger S, Gibon E, Goodman SB, Li G. Mesenchymal stem cells homing to improve bone healing. J. Orthop. Transl. 9, 19–27 (2017).
PubMed
Google Scholar
21.
Lv FJ, Tuan RS, Cheung KM, Leung VY. Concise review: the surface markers and identity of human mesenchymal stem cells. Stem Cells 32(6), 1408–1419 (2014).
PubMed
Google Scholar
22.
Lv F, Lu M, Cheung KM, Leung VY, Zhou G. Intrinsic properties of mesemchymal stem cells from human bone marrow, umbilical cord and umbilical cord blood comparing the different sources of MSC. Curr. Stem Cell Res. Ther. 7(6), 389–399 (2012).
PubMed
Google Scholar
23.
Anderson JA, Little D, Toth AP et al. Stem cell therapies for knee cartilage repair: the current status of preclinical and clinical studies. Am. J. Sports Med. 42(9), 2253–2261 (2014).
PubMed
Google Scholar
24.
Zhou WY, Lin JX, Zhao K et al. Single-cell profiles and clinically useful properties of human mesenchymal stem cells of adipose and bone marrow origin. Am. J. Sports Med. 47(7), 1722–1733 (2019).
PubMed
Google Scholar
25.
Cui G-H, Wang YY, Li C-J, Shi C-H, Wang W-S. Efficacy of mesenchymal stem cells in treating patients with osteoarthritis of the knee: a meta-analysis. Exp. Ther. Med. 12(5), 3390–3400 (2016).
PubMed
Google Scholar
26.
Kim SH, Ha CW, Park YB, Nam E, Lee JE, Lee HJ. Intra-articular injection of mesenchymal stem cells for clinical outcomes and cartilage repair in osteoarthritis of the knee: a meta-analysis of randomized controlled trials. Arch. Orthop. Trauma Surg. 139(7), 971–980 (2019).
PubMed
Google Scholar
27.
Xia P, Wang X, Lin Q, Li X. Efficacy of mesenchymal stem cells injection for the management of knee osteoarthritis: a systematic review and meta-analysis. Int. Orthop. 39(12), 2363–2372 (2015).
PubMed
Google Scholar
28.
Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339, b2535 (2009).
PubMed
Google Scholar
29.
Higgins JP, Altman DG, Gotzsche PC et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 343, d5928 (2011).
PubMed
Google Scholar
30.
Phillips B BC, Sackett D, Badenoch D, Straus S, Haynes B, Dawes M. Centre for Evidence-Based Medicine. Levels of evidence and grades of recommendation (2009). www.cebm.net/
Google Scholar
31.
Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med. Res. Methodol. 14, 135 (2014).
PubMed
Google Scholar
32.
Lamo-Espinosa JM, Mora G, Blanco JF et al. Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis: multicenter randomized controlled clinical trial (Phase I/II). J. Transl. Med. 14(1), 246 (2016).
PubMed
Google Scholar
33.
Gupta PK, Chullikana A, Rengasamy M et al. Efficacy and safety of adult human bone marrow-derived, cultured, pooled, allogeneic mesenchymal stromal cells (Stempeucel [R]): preclinical and clinical trial in osteoarthritis of the knee joint. Arthritis Res. Ther. 18(1), 301 (2016).
PubMed
Google Scholar
34.
Vega A, Martin-Ferrero MA, Del Canto F et al. Treatment of knee osteoarthritis with allogeneic bone marrow mesenchymal stem cells: a randomized controlled trial. Transplantation 99(8), 1681–1690 (2015).
PubMed
Google Scholar
35.
Vangsness CT, Farr J, Boyd J, Dellaero DT, Mills CR, Leroux-Williams M. Adult human mesenchymal stem cells delivered via intra-articular injection to the knee following partial medial meniscectomy: a randomized, double-blind, controlled study. J. Bone Joint Surg. Am. 96(2), 90–98 (2014).
PubMed
Google Scholar
36.
Wong KL, Lee KBL, Tai BC, Law P, Lee EH, Hui JHP. Injectable cultured bone marrow-derived mesenchymal stem cells in varus knees with cartilage defects undergoing high tibial osteotomy: a prospective, randomized controlled clinical trial with 2 years’ follow-up. Arthroscopy 29(12), 2020–2028 (2013).
PubMed
Google Scholar
37.
Lu L, Dai C, Zhang Z et al. Treatment of knee osteoarthritis with intra-articular injection of autologous adipose-derived mesenchymal progenitor cells: a prospective, randomized, double-blind, active-controlled, Phase IIb clinical trial. Stem Cell Res. Ther. 10(1), 143 (2019).
PubMed
Google Scholar
38.
Koh YG, Kwon OR, Kim YS, Choi YJ. Comparative outcomes of open-wedge high tibial osteotomy with platelet-rich plasma alone or in combination with mesenchymal stem cell treatment: a prospective study. Arthroscopy 30(11), 1453–1460 (2014).
PubMed
Google Scholar
39.
Koh YG, Choi YJ. Infrapatellar fat pad-derived mesenchymal stem cell therapy for knee osteoarthritis. Knee 19(6), 902–907 (2012).
PubMed
Google Scholar
40.
Freitag J, Bates D, Wickham J et al. Adipose-derived mesenchymal stem cell therapy in the treatment of knee osteoarthritis: a randomized controlled trial. Regen. Med. 14(3), 213–230 (2019).
PubMed
Google Scholar
41.
Rodriguez-Merchan EC. Intra-articular injections of mesenchymal stem cells for knee osteoarthritis. Am. J. Orthop. (Belle Mead NJ) 43(12), E282–E291 (2014).
PubMed
Google Scholar
42.
Yubo M, Yanyan L, Li L, Tao S, Bo L, Lin C. Clinical efficacy and safety of mesenchymal stem cell transplantation for osteoarthritis treatment: A meta-analysis. PLoS ONE 12(4), e0175449 (2017).
PubMed
Google Scholar
43.
Dmitrieva RI, Minullina IR, Bilibina AA, Tarasova OV, Anisimov SV, Zaritskey AY. Bone marrow- and subcutaneous adipose tissue-derived mesenchymal stem cells: differences and similarities. Cell Cycle 11(2), 377–383 (2012).
PubMed
Google Scholar
44.
Cho KA, Park M, Kim YH, Woo SY, Ryu KH. RNA sequencing reveals a transcriptomic portrait of human mesenchymal stem cells from bone marrow, adipose tissue, and palatine tonsils. Sci. Rep. 7(1), 17114 (2017).
PubMed
Google Scholar
45.
Furuhashi K, Tsuboi N, Shimizu A et al. Serum-starved adipose-derived stromal cells ameliorate crescentic GN by promoting immunoregulatory macrophages. J. Am. Soc. Nephrol. 24(4), 587–603 (2013).
PubMed
Google Scholar
|